Upgrade to SI Premium - Free Trial

Imunon (IMNN)

1.58 +0.02 (1.28%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/16/26)

Latest Headlines

Imunon to host R&D day on Phase 3 ovarian cancer trial in September August 26, 2026 8:30 AM - StreetInsider Imunon to hold R&D Day on Sept. 23 focused on ovarian cancer trial August 26, 2026 8:30 AM - StreetInsider IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001  August 26, 2026 8:30 AM - Globe NewsWire IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001  August 26, 2026 8:30 AM - StreetInsider Form 4 Imunon, Inc. For: Aug 14 Filed by: Lindborg Stacy August 17, 2026 4:23 PM - SEC Filing Form 4 Imunon, Inc. For: Aug 14 Filed by: Faller Douglas Vincent August 17, 2026 4:22 PM - SEC Filing Form 4 Imunon, Inc. For: Aug 14 Filed by: Tardugno Michael H August 17, 2026 4:21 PM - SEC Filing Form 4 Imunon, Inc. For: Aug 14 Filed by: Eylward Susan August 17, 2026 4:18 PM - SEC Filing Form SCHEDULE 13G/A Imunon, Inc. Filed by: ARMISTICE CAPITAL, LLC August 14, 2026 10:17 AM - SEC Filing Form 8-K Imunon, Inc. For: Aug 11 August 11, 2026 5:00 PM - SEC Filing Imunon (IMNN) Tops Q2 EPS by 39c August 11, 2026 9:41 AM - StreetInsider Form 10-Q Imunon, Inc. For: Jun 30 August 11, 2026 8:31 AM - SEC Filing Form 8-K Imunon, Inc. For: Aug 11 August 11, 2026 8:02 AM - SEC Filing IMUNON Reports Second Quarter 2026 Financial Results and Provides Business Update August 11, 2026 8:00 AM - StreetInsider Form 4 Imunon, Inc. For: Jul 31 Filed by: Pellizzari Christine A August 4, 2026 4:18 PM - SEC Filing Form 4 Imunon, Inc. For: Jul 31 Filed by: Dentzer James E August 4, 2026 4:17 PM - SEC Filing Form 4 Imunon, Inc. For: Jul 31 Filed by: Fritz Frederick J. August 4, 2026 4:16 PM - SEC Filing Form 4 Imunon, Inc. For: Jul 31 Filed by: Braun Donald P August 4, 2026 4:14 PM - SEC Filing Form 4 Imunon, Inc. For: Jul 31 Filed by: Eylward Susan August 4, 2026 4:14 PM - SEC Filing Form 4 Imunon, Inc. For: Jul 31 Filed by: Tardugno Michael H August 4, 2026 4:12 PM - SEC Filing Form 4 Imunon, Inc. For: Jul 31 Filed by: Faller Douglas Vincent August 4, 2026 4:11 PM - SEC Filing Form 4 Imunon, Inc. For: Jul 31 Filed by: Lindborg Stacy August 4, 2026 4:11 PM - SEC Filing IMUNON to Hold Second Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, August 11, 2026 August 4, 2026 8:00 AM - StreetInsider Imunon says Phase 3 ovarian cancer trial enrollment ahead of schedule July 30, 2026 9:00 AM - StreetInsider IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer July 30, 2026 9:00 AM - StreetInsider Imunon to present IMNN-001 ovarian cancer data at AACR conference July 23, 2026 9:25 AM - StreetInsider IMUNON to Present IMNN-001 Data at Inaugural AACR Conference on Drug Discovery and Development July 23, 2026 9:25 AM - StreetInsider Form 4 Imunon, Inc. For: Jul 17 Filed by: Tardugno Michael H July 21, 2026 4:17 PM - SEC Filing Form 4 Imunon, Inc. For: Jul 17 Filed by: Eylward Susan July 21, 2026 4:16 PM - SEC Filing Form 4 Imunon, Inc. For: Jul 17 Filed by: Faller Douglas Vincent July 21, 2026 4:15 PM - SEC Filing Form 4 Imunon, Inc. For: Jul 17 Filed by: Lindborg Stacy July 21, 2026 4:14 PM - SEC Filing Imunon reports Phase 2 MRD data for IMNN-001 in ovarian cancer July 21, 2026 9:00 AM - StreetInsider IMUNON Reports Positive Phase 2 MRD Clinical Data for IMNN-001, Demonstrating the Successful Overcoming of Historical IL-12 Safety Barriers in Frontline Ovarian Cancer July 21, 2026 9:00 AM - StreetInsider Form 4 Imunon, Inc. For: Jul 02 Filed by: Tardugno Michael H July 7, 2026 5:05 PM - SEC Filing Form 3 Imunon, Inc. For: Jul 01 Filed by: Blacher Joshua July 7, 2026 5:01 PM - SEC Filing Form 4 Imunon, Inc. For: Jul 02 Filed by: Eylward Susan July 7, 2026 4:58 PM - SEC Filing Form 4 Imunon, Inc. For: Jul 02 Filed by: Faller Douglas Vincent July 7, 2026 4:57 PM - SEC Filing Form 4 Imunon, Inc. For: Jul 02 Filed by: Lindborg Stacy July 7, 2026 4:56 PM - SEC Filing Imunon names new interim CFO as predecessor retires June 30, 2026 4:40 PM - StreetInsider Form 8-K Imunon, Inc. For: Jun 29 June 30, 2026 4:32 PM - SEC Filing Form 4 Imunon, Inc. For: Jun 25 Filed by: Faller Douglas Vincent June 29, 2026 4:36 PM - SEC Filing Form 4 Imunon, Inc. For: Jun 25 Filed by: Eylward Susan June 29, 2026 4:34 PM - SEC Filing Form 4 Imunon, Inc. For: Jun 25 Filed by: Tardugno Michael H June 29, 2026 4:23 PM - SEC Filing Form 4 Imunon, Inc. For: Jun 25 Filed by: Lindborg Stacy June 29, 2026 4:21 PM - SEC Filing Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing June 26, 2026 8:35 AM - StreetInsider Form 4 Imunon, Inc. For: Jun 18 Filed by: Tardugno Michael H June 23, 2026 7:59 PM - SEC Filing Form 4 Imunon, Inc. For: Jun 18 Filed by: Lindborg Stacy June 23, 2026 4:18 PM - SEC Filing Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th June 23, 2026 8:35 AM - Globe NewsWire Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th June 23, 2026 8:35 AM - StreetInsider IMUNON's Phase 3 ovarian cancer trial cleared to continue by safety panel June 23, 2026 8:00 AM - StreetInsider IMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification June 23, 2026 8:00 AM - StreetInsider IMUNON to Present at the Life Sciences Investor Forum on June 25th June 22, 2026 4:15 PM - StreetInsider Form S-8 Imunon, Inc. June 17, 2026 4:16 PM - SEC Filing Form 8-K Imunon, Inc. For: Jun 16 June 16, 2026 5:30 PM - SEC Filing Form 4 Imunon, Inc. For: Jun 05 Filed by: Tardugno Michael H June 9, 2026 5:16 PM - SEC Filing Form 4 Imunon, Inc. For: Jun 05 Filed by: Lindborg Stacy June 9, 2026 4:14 PM - SEC Filing Full Article List